Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,021,048
-
Total 13F shares
-
85,664,154
-
Share change
-
-1,981,643
-
Total reported value
-
$5,483,381,207
-
Put/Call ratio
-
78%
-
Price per share
-
$63.82
-
Number of holders
-
419
-
Value change
-
-$371,527,547
-
Number of buys
-
207
-
Number of sells
-
247
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q1 2025
As of 31 Mar 2025,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
419 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,664,154 shares.
The largest 10 holders included
BlackRock, Inc., Capital International Investors, VANGUARD GROUP INC, STATE STREET CORP, JANUS HENDERSON GROUP PLC, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, FARALLON CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, and T. Rowe Price Investment Management, Inc..
This page lists
420
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.